Package 50268-049-12

Brand: abacavir

Generic: abacavir
NDC Package

Package Facts

Identity

Package NDC 50268-049-12
Digits Only 5026804912
Product NDC 50268-049
Product ID 50268-049_47e2137a-9afb-1285-e063-6294a90a4979
Description

20 BLISTER PACK in 1 BOX (50268-049-12) / 1 TABLET in 1 BLISTER PACK (50268-049-11)

Marketing

Marketing Status
Marketed Since 2020-04-10
Brand abacavir
Generic abacavir
Sample Package No

Linked Drug Pages (1)

Abacavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "47e2137a-9afb-1285-e063-6294a90a4979", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["a2f06528-f3c5-2466-e053-2995a90ae18a"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 BOX (50268-049-12)  / 1 TABLET in 1 BLISTER PACK (50268-049-11)", "package_ndc": "50268-049-12", "marketing_start_date": "20200410"}], "brand_name": "Abacavir", "product_id": "50268-049_47e2137a-9afb-1285-e063-6294a90a4979", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "50268-049", "generic_name": "Abacavir", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA091560", "marketing_category": "ANDA", "marketing_start_date": "20200410", "listing_expiration_date": "20271231"}